Alpelisib/iNOS Inhibitor/Nab-paclitaxel in Patients With HER2 Negative Metaplastic Breast Cancer (MpBC)

Clinical trial NCT05660083 · RECRUITING

Trial details

NCT number: NCT05660083
Sponsor: The Methodist Hospital Research Institute
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

HER2-negative Breast Cancer Metastatic Breast Cancer Metaplastic Breast Carcinoma TNBC - Triple-Negative Breast Cancer

Start date: 2023-01-12
Primary completion: 2026-12-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.